Back

Efficacy and safety of pulsed-field ablation in atrial fibrillation patients with high versus low comorbidity burden: a multicenter analysis

14 April 2026 (13:30 - 14:15)
Organised by: Logo
Congress Presentation Part of: Outcomes of pulsed field ablation in atrial fibrillation (2) Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mrs Esther Roth

University Hospital Frankfurt, Frankfurt (Germany)

7 More presentations in this session

Presentation thumbnail
Patient-reported outcome measures following pulsed-field ablation versus thermal ablation of atrial fibrillation: results of the prospective PROMs-PFA study
Doctor M. Mills (Sheffield, GB)
Abstract Slides Video
Presentation thumbnail
Impact of pulsed field ablation on outcome in obese patients undergoing pulmonary vein isolation for atrial fibrillation
Ms K. Yang (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Lesion characteristics after atrial fibrillation ablation using pulsed field ablation
Doctor M. Foti (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Pulsed field ablation for pulmonary vein isolation and additional lesion set in patients with persistent atrial fibrillation: safety, efficacy and long-term outcome from a nationwide experience
Doctor M. Schiavone (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Pulsed field ablation for pulmonary vein isolation in atrial fibrillation: comparison between mapping integrated and non integrated 3D mapping systems
Doctor L. Rossi (Piacenza, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Outcomes of pulsed field ablation in atrial fibrillation (2)

The Event

Event poster

EHRA 2026

14 April 2026 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Trends in comorbidity burden and periprocedural outcomes among patients undergoing catheter ablation for atrial fibrillation
thumbnail
Congress Session
Atrial fibrillation catheter ablation (1)
thumbnail
Congress Presentation
Multimorbidity increases risk of atrial fibrillation recurrence after cryoballoon ablation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources